Mitsui Chemicals, Inc.

Mitsui Chemicals, Inc.

11.34
USD
+1.34
(+13.40%)
1.79EPS
8.30P/E
4.48BMarket Cap
Feb 09Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
3,906.4
3,867.98
3,354.78
3,026.95
3,322.92
3,753.27
3,463.84
3,117.31
4,142.13
4,881.93
4,598.14
4,781.47
4,444.02
5,047.58
Basic EPS, GAAP
-62.71
43.07
57.32
161.9
179.05
192.65
87.19
148.89
282.51
215.42
131.39
85.21
91.55
234.89
Free Cash Flow per Basic Share
-24.98
51.93
260.93
147.17
75.01
136.01
108.99
251.45
-60.7
-95.12
19.31
164.11
- -
- -
Dividend per Share
14.99
5
17.49
22.48
45.04
47.78
50.07
49.78
52.72
62.76
64.95
72.87
- -
76.84
Book Value per Share
880.33
1,013.91
953.67
1,122.97
1,286.4
1,413.3
1,384.14
1,550.05
1,842.56
2,068.26
2,267.28
2,262.24
2,347.33
2,458.69
Tangible Book Value per Share
700.17
832.31
853.37
1,035.1
1,207.26
1,347.03
1,315.52
1,497.01
1,678.84
1,890.89
2,066.5
2,029.36
2,081.37
1,891.55
Basic Weighted Avg Shares
401
401
401
400
400
395
390
389
389
385
381
378
376
363
Sales/Revenue/Turnover
1,566,046
1,550,076
1,343,898
1,212,282
1,328,526
1,482,909
1,349,522
1,211,725
1,612,688
1,879,547
1,749,743
1,809,164
1,668,754
1,834,246
Operating Margin (%)
1.59
2.71
5.28
8.43
7.79
6.3
4.45
5.95
7.53
5.71
3.53
3.64
3.39
6.39
Depreciation Expense
48,143
48,251
48,640
44,057
45,654
49,504
76,009
76,621
84,222
92,080
95,249
99,768
- -
- -
Net Income, GAAP
-25,138
17,261
22,963
64,839
71,585
76,115
33,970
57,873
109,990
82,936
49,999
32,242
34,378
85,357
Effective Tax Rate (%)
- -
32.03
28.65
13.89
16.12
17.83
29.93
13.5
16.08
23.14
26.67
40.5
31.63
22.89
Profit Margin (%)
-1.61
1.11
1.71
5.35
5.39
5.13
2.52
4.78
6.82
4.41
2.86
1.78
2.06
4.65
Working Capital
269,959
283,209
263,951
286,155
288,221
304,604
296,160
321,267
326,876
398,842
474,000
435,244
402,058
301,127
LT Debt
389,595
368,996
339,299
304,228
305,963
322,749
313,237
293,495
319,471
369,786
432,670
455,489
443,464
427,965
Total Equity
409,647
471,299
443,237
514,635
587,222
631,063
609,707
682,157
807,122
883,303
984,806
970,604
988,784
1,041,621
Return on Invested Capital (%)
- -
2.83
5.21
9.36
8.62
6.95
3.91
5.73
9.21
6.37
3.22
2.69
2.93
5.91
Return on Capital (%)
- -
1.51
2.19
6.51
6.88
6.41
2.76
4.99
8.38
5.76
3.39
1.77
1.92
4.55
Return on Common Equity (%)
-6.89
4.55
5.83
15.59
14.89
14.32
6.28
10.18
16.66
11.06
6.06
3.77
4.01
9.79

Capital Structure

JPY

•

in mil. unless spec.
Mar'26
Jun'27
Sep'27
ST Debt
296,727
383,778
476,554
LT Borrowings
443,464
438,184
427,965
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
368
362
362
Market Capitalization
687,826
634,944
705,512

Working Capital

JPY

•

in mil. unless spec.
Mar'26
Jun'27
Sep'27
Total Current Assets
993,159
1,112,518
1,168,478
Cash, Cash Equivalents & STI
217,862
257,671
257,113
Accounts Receivable, Net
327,640
349,600
355,131
Inventories
414,466
467,246
522,976
Total Current Liabilities
591,101
702,930
867,351
Payables & Accruals
- -
- -
- -
ST Debt
296,727
383,778
476,554
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
8.59%
7.94%
1.87%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
21.09%
-0.63%
6.62%
Sales/Revenue/Turnover
3.06%
7.67%
-7.76%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
449,471
440,880
448,485
470,328
1,809,164
2026
415,350
398,240
405,121
450,043
1,668,754
2027
460,046
519,036
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
47.01
11.41
41
-14.6
85.21
2026
1.94
18.93
39.14
31.55
91.55
2027
88.71
78.29
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
34.97
- -
37.77
- -
72.87
2026
37.47
- -
37.5
- -
- -
2027
38.16
- -
- -
- -
- -

Company Description

CEO
Satoshi Ichimura
Full Time Employees
16,967
Sector
Process industries
Industry
Chemicals: major diversified
Address
Tokyo Midtown Yaesu Tokyo TY Japan 104-0028
IPO Date
Oct 5, 1962
Business
Mitsui Chemicals, Inc. (4183.T) manufactures and markets a broad portfolio of advanced chemicals and materials for mobility, health care, food and packaging, basic materials, and other applications. The company produces elastomers, performance compounds, functional polymers, polypropylene compounds, and performance polymers for automotive and industrial uses; vision care materials including ophthalmic lens materials, photochromic lens materials, and coating materials, nonwoven fabrics, dental materials, personal care materials, and raw materials for pharmaceuticals and cosmetics in health care; coating and engineering materials, performance films and sheets, and agrochemical products for food and packaging; ethylene, propylene, polyethylene, polypropylene, catalysts, phenols, purified terephthalic acid, PET, polyurethane materials, and industrial chemicals in basic materials; as well as semiconductor solutions including electronic component processing materials, optical materials, and lithium-ion battery materials, imaging solutions such as lens materials, reflective films, and LCD and OLED sealing materials, and functional food packaging materials. Founded in 1912 and headquartered in Tokyo, Japan, Mitsui Chemicals operates production facilities and sales offices across Japan, China, Asia, the Americas, Europe, and other international markets, with regional headquarters in China, Germany, the United States, and Singapore. In recent developments, the company launched its second corporate venture capital fund, 321Catalyst™, with a $60 million size and a 10-year life, managed by new subsidiary 321Catalyst Ventures, Inc., to invest in startups across life & healthcare, mobility, ICT, sustainability, and other sectors as part of VISION 2030; fully acquired Nippon Aluminum Alkyls, a producer of co-catalysts for polyolefins; signed a memorandum of understanding with Idemitsu Kosan and Sumitomo Chemical to integrate Sumitomo's PP and LLDPE businesses into Prime Polymer to enhance domestic polyolefin competitiveness; entered an MOU with Asahi Kasei and Mitsubishi Chemical for a limited liability partnership on ethylene manufacturing facilities in western Japan; and partnered with Polyplastics on marketing operations for engineering plastic products, while expanding R&D and manufacturing through subsidiaries like SDC Technologies in the United States and Kulzer in EMEA, the Americas, and Saudi Arabia.

Company News

  • Mitsui Chemicals to Acquire JSR With Development Bank of Japan for $8.8 Billion

  • Mitsui Chemicals Launches InnoCell™ P-Type High Oxygen-Permeable Culture Plates to Accelerate Organoid-Based Drug Discovery

  • Mitsui Chemicals, Inc. (OTCMKTS:MITUY) Short Interest Update

  • Contrasting Neo Performance Materials (OTCMKTS:NOPMF) and Mitsui Chemicals (OTCMKTS:MITUY)

  • 2026 Mitsui Chemicals Catalysis Science Awards

  • Mitsui Chemicals Group partners PLASTIFY for beach cleaning at Coney Island

  • Mitsui Chemicals Group donates posica™ kukkiri™ film to Jamiyah Nursing Home

  • Mitsui Chemicals Group to exhibit at ProPak Asia 2025

  • Mitsui Chemicals Launches New Corporate Venture Capital Fund ‘321Catalyst™'

  • Mitsui Chemicals Catalysis Science Awards Celebrate 20-year Milestone

  • Mitsui Chemicals and ARRK Supply Materials for High-Performance Concept Car

  • Mitsui Chemicals Singapore R&D Centre: Donation of posica™ kukkiri™ film to Jamiyah Nursing Home

  • Mitsui Chemicals Group and ARRK Thailand to Organize the First MotionTech 2024 Exhibition

  • Mitsui Chemicals Develops Diffrar™ Optical Polymer Wafers for AR Glasses

  • Japan's Mitsui, others to jointly study hydrogen, ammonia supply chain in Osaka

  • 2024 Mitsui Chemicals Catalysis Science Awards

  • Mitsui Chemicals' MR™ High Refractive Index Ophthalmic Lens Monomers Picked Up by Costco as Standard Option for Glasses